Implantica adds a ninth RefluxStop™ Center of Excellence

17th December, 2024

Deepens market penetration in Italy with several more lined up to start near-term

image credit- shutterstock

image credit- shutterstock

Implantica AG, a medtech company at the forefront of introducing advanced technology into the body, such as the unique device RefluxStop™ for the treatment of acid reflux, announces the first RefluxStop™ procedures were completed this month by Dr Günther Sitzmann, head of General Surgery Department at Ospedale di Brunico, part of Azienda Sanitaria dell'Alto Adige, Brunico, Italy.


The demand for RefluxStop™ continues with Ospedale di Brunico the ninth leading anti-reflux hospital in Italy to offer the RefluxStop™ procedure. Several new centers are lined up to get started in the coming months. RefluxStop™ has been performed in over 1000 patients across Europe, as top foregut surgeons turn to this innovative technology to help their chronic GERD patients.

The RefluxStop™ procedure addresses the root cause of GERD by restoring the natural anatomy and physiology of the body. The unique mechanism of action of RefluxStop™ allows the surgeon to restore the anti-reflux barrier without encircling the food passageway, thus making a surgical solution for GERD available to countless patients who may not have been candidates for traditional surgical GERD procedures.

© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer